When was Triomics founded?

Triomics was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is Triomics located?

Triomics is headquartered in San Francisco, United States. It is registered at VILLA NO. D-103, PLOT NO. BGH-A, UPSIDC HOUSING SECTOR, Gautam Buddha Nagar, SURAJPUR, Uttar Pradesh, India, 201310.

Who is the current CEO of Triomics?

Sarim Khan of Triomics. They have also founded 1 company.

How many employees does Triomics have?

As of Mar 31, 2026, the latest employee count at Triomics is 1.

Is Triomics a funded company?

Triomics is a funded company, having raised a total of $28.9M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2021.

When was the latest funding round of Triomics?

Triomics' latest funding was a $***** Series B round on May 09, 2024, with participation from 4 investors.

Where does Triomics rank among its competitors?

Triomics ranks 24th amongst 295 active competitors, of which 51 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Verily, which secured $300M in Mar, 2026.

Who are the top competitors of Triomics?

Triomics' top competitors include Medidata, IQVIA and Verily. Among them, Verily secured the most recent funding round in March, 2026.

Triomics - 2026 Company Profile, Team, Funding & Competitors

Triomics is a series B company based in San Francisco (United States), founded in 2020 by Hrituraj Singh and Sarim Khan. It operates as a Provider of clinical research and clinical trial tracking software. Triomics has raised $28.9M in funding from Y Combinator. The company has 295 active competitors, including 51 funded and 42 that have exited. Its top competitors include companies like Medidata, IQVIA and Verily.

Company Details

Provider of clinical research and clinical trial tracking software. The features of the software include an end-to-end platform for running clinical trials, unifying the workflows of clinical care and clinical research, and eliminating the operational inefficiencies in data collection, patient recruitment, and other laborious tasks involved in clinical research.

Website: www.triomics.com/
Email ID: *****@triomics.com
Phone Number: +1 **********
Registered Address: VILLA NO. D-103, PLOT NO. BGH-A, UPSIDC HOUSING SECTOR, Gautam Buddha Nagar, SURAJPUR, Uttar Pradesh, India, 201310

Key Metrics

Founded Year

2020

Location

San Francisco, United States

Stage

Series B

Total Funding

$28.9M in 3 rounds

Latest Funding Round

Series B, May 09, 2024, $*****

Investors

Y Combinator & 4 more

Ranked

24^th among 295 active competitors

Employee Count

1 as on Mar 31, 2026

Similar Companies

Medidata & 2640 more

View Triomics' full profile

Triomics is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
TRIOMICS HEALTHCARE PRIVATE LIMITED CIN: U85300UP2020PTC136648 , India, Active	Oct 20, 2020	$66.7K (As on Mar 31, 2025)	32 (As on Mar 31, 2025)
Triomics, Inc CIN: 861771548 , United States, Active		-	10 (As on Dec 31, 2024)	-

Triomics has raised a total funding of $28.9M over 3 rounds. Its first funding round was on 2021. Its latest funding round was a Series B round on May 09, 2024 for $*****. 4 investors participated in its latest round. Triomics has 5 institutional investors.

Here is the list of recent funding rounds of Triomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 09, 2024	6333779	Series B	8097344	9140483	4231623	4635463
Dec 12, 2022	1300269	Series A	5773990	7790209	3255222	3884747
2021	5985	Seed	3714	8692	Y Combinator	4961

Access funding benchmarks and valuations. Sign up today!

View details of Triomics's funding rounds and investors

The founders of Triomics are Hrituraj Singh and Sarim Khan. Sarim Khan is the CEO of Triomics.

Here are the details of Triomics' key team members:

Hrituraj Singh: Co-Founder & CTO of Triomics.
Contact Info: 1 email address
Sarim Khan: Co-Founder & CEO of Triomics.
Contact Info: 1 email address

View details of Triomics's Founder profiles and Board Members

Triomics' employee count trend

Triomics has 1 employees as of Mar 26. Here is Triomics's employee count trend over the years:

Uncover Triomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Triomics include Medidata, IQVIA and Verily. Here is the list of Top 10 competitors of Triomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Fisher Lynch Capital ... & 9 others	80/100
3rd	Verily 2015, Dallas (United States), Series D	Developer of precision health platforms and solutions using artificial intelligence	$2.8B	Silver Lake, Temasek & 9 others	78/100
4th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	73/100
5th	Viz.ai 2016, San Francisco (United States), Series D	Provider of AI-powered care coordination platform for disease detection and treatment	$252M	Insight Partners, Kleiner Perkins & 16 others	69/100
6th	Tempus 2015, Chicago (United States), Public	AI-based precision medicine solutions for oncology	$1.05B	New Enterprise Associates, T. Rowe Price ... & 10 others	68/100
7th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	Merck Global Health Innovation Fund, MPM Capital ... & 5 others	66/100
8th	BrightInsight 2017, San Jose (United States), Series C	Provider of digital health solutions for clinical trials	$179M	General Catalyst, Eclipse & 8 others	64/100
9th	Sanguine 2010, Los Angeles (United States), Series B	Building a databank of patient-derived data for advanced research	$5.53M	Broadoak Capital Partners, FCVC & 9 others	64/100
10th	Wcg Clinical 2012, Princeton (United States), Acquired	CRO offering regulatory and ethical review services for clinical research	-	Prospect Capital, Ares Capital Corporation ... & 5 others	64/100
24th	Triomics 2020, San Francisco (United States), Series B	Provider of clinical research and clinical trial tracking software	$28.9M	General Catalyst, Nexus Venture Partners & 3 others	53/100